Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mind Medicine (MindMed) Inc
N.MMED.WR
Primary Symbol:
MNMD
Alternate Symbol(s):
N.MMED.WS
|
N.MMED.WA
|
N.MMED
Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen...
drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNMD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
Next
(1)
•••
slickk
X
View Profile
View Bullboard History
Comment by
slickk
on Nov 25, 2020 9:07am
RE:You can buy A LOT of LSD with 25 MILLION ; - )
Great news indeed. See you at $3.00
(800)
•••
SouthernTierTom
X
View Profile
View Bullboard History
Post by
SouthernTierTom
on Nov 25, 2020 8:43am
You can buy A LOT of LSD with 25 MILLION ; - )
Great day for shareholders... 25 Million in the kitty to start humane trials GLTA ; - )
(2)
•••
manymoney
X
View Profile
View Bullboard History
Post by
manymoney
on Nov 25, 2020 8:22am
nasdaq
Nasdaq has tiers , much like TSX venture ...prove yourself on lower tier , then move up
(41)
•••
Eskimoman
X
View Profile
View Bullboard History
Comment by
Eskimoman
on Nov 24, 2020 9:16pm
RE:RE:RE:RE:RE:RE:Just a bunch of kids
...there will be a share consolidation to achieve the pricing they need to get listed...than another raise.....they need millions to keep this going....
(23)
•••
Gordinno
X
View Profile
View Bullboard History
Comment by
Gordinno
on Nov 24, 2020 8:27pm
RE:RE:RE:RE:RE:RE:Just a bunch of kids
Yea lot of different rules but they put in application so must be eligible
(10)
•••
Reidraider
X
View Profile
View Bullboard History
Comment by
Reidraider
on Nov 24, 2020 7:12pm
RE:RE:RE:RE:RE:Just a bunch of kids
I downloaded a file from nasdaq dated June 2020 I dont quite understand all the different possibilities on the charts but it appears unless mmed meets very specific terms its a 4 dollar bid or 3
...more
(23)
•••
Gordinno
X
View Profile
View Bullboard History
Post by
Gordinno
on Nov 24, 2020 5:59pm
Interview
https://youtu.be/Vyehp7id9VY
(1)
•••
Scotty2112
X
View Profile
View Bullboard History
Comment by
Scotty2112
on Nov 24, 2020 5:31pm
RE:RE:RE:Great start to the week
i got in at 50 cents and never sold a bit :)
(23)
•••
Gordinno
X
View Profile
View Bullboard History
Comment by
Gordinno
on Nov 24, 2020 5:25pm
RE:RE:RE:RE:Just a bunch of kids
Not on the nasdaq capital market
(10)
•••
Reidraider
X
View Profile
View Bullboard History
Comment by
Reidraider
on Nov 24, 2020 4:28pm
RE:RE:RE:Just a bunch of kids
it needs to double b4 it hits the nasdaq
(23)
•••
Gordinno
X
View Profile
View Bullboard History
Comment by
Gordinno
on Nov 24, 2020 3:49pm
RE:RE:Just a bunch of kids
Agree but when it hits the Nasdaq it will double
(2)
•••
InvestorSara
X
View Profile
View Bullboard History
Comment by
InvestorSara
on Nov 24, 2020 2:02pm
RE:Just a bunch of kids
As much as we don't like the New Kids on the Block throwing away money we must remember we all started somewhere too. Flipping profits of $100, then $1000, $10k $100k.... Let them have their fun
...more
(800)
•••
SouthernTierTom
X
View Profile
View Bullboard History
Comment by
SouthernTierTom
on Nov 24, 2020 1:37pm
RE:Just a bunch of kids
Based on the current valuation GREEN.. What would make said "serious investers" hang around? TIA
(23)
•••
Gordinno
X
View Profile
View Bullboard History
Comment by
Gordinno
on Nov 24, 2020 12:39pm
RE:RE:MindMed to Launch Albert, A Digital Medicine Division
Wouldnt be so fast on that
(3)
•••
mushrooms
X
View Profile
View Bullboard History
Post by
mushrooms
on Nov 24, 2020 12:27pm
MYCO could be the next to run like MMED
Mydecine MYCO London Stock Exchange (LSE) uplisting is coming soon. Just as MMED has seen the hype to a $660M+ market cap on an upcoming NASDAQ listing, MYCO's $44M market cap is about to do the
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income